Internalizing erbb2 antibodies

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/13 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61K 51/10 (2006.01) C07K 16/28 (2006.01) C07K 16/30 (2006.01) C07K 16/32 (2006.01) C07K 16/40 (2006.01) C07K 19/00 (2006.01) C07K 14/705 (2006.01) C12N 9/12 (2006.01)

Patent

CA 2326377

This invention provides novel erbB2-binding internalizing antibodies. The antibodies, designated F5 and C1, specifically bind to c-erbB2 antigen and, upon binding, are readily internalized into the cell bearing the c-erbB2 marker. Chimeric molecules comprising the F5 and/or C1 antibodies attached to one or more effector molecules are also provided.

L'invention porte sur de nouveaux anticorps d'internalisation à liaison ERBB2. Les anticorps, appelés F5 et C1, se lient spécifiquement à l'antigène c-erbB2 et, lors de la liaison, sont facilement internalisés dans la cellule supportant le marqueur c-erbB2. L'invention porte également sur des molécules chimères comprenant les anticorps F5 et/ou C1 liés à une ou plusieurs molécules effectrices.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Internalizing erbb2 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Internalizing erbb2 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Internalizing erbb2 antibodies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1683235

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.